Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Loss of MiR-143 and MiR-145 Inhibits Hematopoietic Stem Cell Self-Renewal through Dysregulated TGFβ Signaling

Jeffrey C Lam, BSc, Joanna Wegrzyn-Woltosz, PhD, Rawa Ibrahim, BSc, Kate Slowski, BSc, Patricia Umlandt, BSc, Megan Fuller, BSc, Aly Karsan, MD

Blood (2014) 124 (21): 527.

https://doi.org/10.1182/blood.V124.21.527.527

Published: 2014

Journal Articles

Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206

Eric Sanchez, Cydney M Nichols, Alison C Lam, Mingjie Li, Cathy Wang, Colsen A Beveridge, Jacob T Lista, Andrew Leu, Kevin Delijani, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 5107.

https://doi.org/10.1182/blood.V118.21.5107.5107

Published: 2011

Journal Articles

Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Eric Sanchez, Cydney M Nichols, Alison C Lam, Mingjie Li, Jennifer Li, Cathy Wang, Colsen A Beveridge, Jacob T Lista, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 2946.

https://doi.org/10.1182/blood.V118.21.2946.2946

Published: 2011

Journal Articles

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Jennifer Li, Andrew Leu, Mingjie Li, Ethan D Hobel, Kevin Delijani, Joleen T Qiu, David Ramirez, Alison C Lam, Cathy Wang, Eric Sanchez, Benjamin Bonavida, Ph.D, Haiming Chen, James R. Berenson, MD

Blood (2011) 118 (21): 2917.

https://doi.org/10.1182/blood.V118.21.2917.2917

Published: 2011

Journal Articles

Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells

MJ Aman, G Rudolf, J Goldschmitt, WE Aulitzky, C Lam, C Huber, C Peschel

Blood (1993) 82 (8): 2371–2378.

https://doi.org/10.1182/blood.V82.8.2371.2371

Published: 1993

Journal Articles

Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates

P Mayer, C Lam, H Obenaus, E Liehl, J Besemer

Blood (1987) 70 (1): 206–213.

https://doi.org/10.1182/blood.V70.1.206.206

Published: 1987

NARROW

Loss of MiR-143 and MiR-145 Inhibits Hematopoietic Stem Cell Self-Renewal through Dysregulated TGFβ Signaling

Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206

Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells

Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates

Email alerts

ASH Publications

American Society of Hematology

Loss of MiR-143 and MiR-145 Inhibits Hematopoietic Stem Cell Self-Renewal through Dysregulated TGFβ Signaling

Anti-Myeloma Effects of the Novel Anthracycline Derivative INNO-206

Efficacy and Tolerability of CEP-18770 in Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Frequent Dysregulation of Fc Gamma Receptor IIb (Fc γRIIb) and Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling Occurs in Multiple Myeloma (MM) Patients

Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells

Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only